Consistently, the protein expression of GNAI3 was higher in the more aggressive high-grade gliomas in the Human Protein Atlas immunohistology study (Figure S1A), while that of ACADSB exhibited a reverse trend (Figure S1B). The gene discussed is GNAI3; the disease is glioma.